biotech fireworks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech fireworks

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: tnsaf	1/18/2018 9:54:09 PM
	of 7424

BGNE +15% at high closed +12% U.S. Investors Swarm China's Biotech Leader Barrons.comJanuary 18, 2018 Depositary shares of the up-and-coming Chinese biotech firm BeiGene (BGNE) jumped 15% today, to $118, after the company successfully raised $750 million in a follow-on share offering. BeiGene has promising drugs under development, ample funding, and international partners like Celgene (CELG) and Boehringer Ingelheim. The Beijing-based drug developer is one of China’s leading hopes as that country tries to become one of the world’s medical innovators.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next